Insmed
INSM
$24.72
Share price
-1.12%
Change (1 day)
22.56%
Change (1 year)
Categories
Insmed (INSM) - Total debt
Total debt on the balance sheet as of December 2023 : $1.20 B
According to Insmed's latest financial reports the company's total debt is $1.20 B. A company’s total debt is the sum of all current and non-current debts.
Insmed - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.20 B | 2.22% |
| 2022-12-31 | $1.17 B | 92.38% |
| 2021-12-31 | $0.61 B | 51.24% |
| 2020-12-31 | $0.40 B | 1.97% |
| 2019-12-31 | $0.39 B | 25.42% |
| 2018-12-31 | $0.31 B | 469.69% |
| 2017-12-31 | $55.56 M | 1.42% |
| 2016-12-31 | $54.79 M | 117.94% |
| 2015-12-31 | $25.14 M | 1.14% |
| 2014-12-31 | $24.85 M | 26.27% |
| 2013-12-31 | $19.68 M | 1.53% |
| 2012-12-31 | $19.38 M | 6824.29% |
| 2011-12-31 | $0.28 M | 70.73% |
| 2010-12-31 | $0.16 M | -21.15% |
| 2009-12-31 | $0.2 M | -90.1% |
| 2008-12-31 | $2.1 M | -37.7% |
| 2007-12-31 | $3.37 M | 6.74% |
| 2006-12-31 | $3.16 M | -50.89% |
| 2005-12-31 | $6.43 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $27.28 B | 2,166.13% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $24.98 B | 1,975.35% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $0.80 B | -32.86% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.39 B | 16.02% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.33 B | -72.01% | 🇺🇸 USA |
 Array Technologies ARRY | $0.73 B | -39.33% | 🇺🇸 USA |